Medical Technology

Scott Whitaker says tariff-free trade is critical to maintaining the industry’s competitiveness and ensuring patient access to lifesaving products

CorWave advances heart failure treatment with a groundbreaking LVAD, showcasing promising preclinical results and paving the way for human trials.

This is the first time an implantable, long-term EEG monitoring device has been authorized for use in the United States.

The company received the designation for its atrioventricular interval modulation therapy, a novel pacemaker-based treatment aimed at reducing blood pressure in patients with uncontrolled hypertension and elevated cardiovascular risk.

Move positions Zimmer Biomet in the foot and ankle space

Ohio State researchers develop system that analyzes health by how they walk

Key considerations around selecting the right network partner include what the partner will do with the data, the interoperability partner’s experience and expertise, the quality and the usability of the data it will deliver, and the partner’s financial strength.

Robotic removal of blood clots could dramatically change stroke care

Mark E. Rosenberg, MD, FASN, dean of the American University of the Caribbean School of Medicine, shares his perspectives on education, Match 2025 and more.

The newly cleared system uses advanced identification and antimicrobial susceptibility testing algorithms to support the interpretation of complex microbiological data.

$8 billion division grew 4.1% for the quarter

Experts say the lack of a consistent payment mechanism through Medicare has become a major roadblock to adoption.

RSP Systems achieves major milestone in non-invasive glucose monitoring technology

The impact of these tariffs on the global market has been significant. What's next for investors?

Are your patients' medications about to get more expensive?

American Heart Association says physicians should consider how digital drivers of health affect patients.

The company also expects to submit its application for 510(k) clearance for its OneRF Trigeminal Nerve Ablation System in May, sooner than expected.

Swiss-based company’s plant will increase capacity to meet demand for autoinjectors

Between President Trump's tariff plan and sweeping layoffs at the FDA and HSS, the medical device industry is facing an uncertain future.

Under the terms, Boston Scientific will pay about $443 million upfront, plus up to $221 million if regulatory milestones occur.

Report shows industry hitting the $1.3 trillion mark by 2029

Omid Veiseh, PhD, faculty director of the Rice Biotech Launchpad, discusses his organization’s mission to create innovative biotechnology based on patient need.

Merged organizations pledge to advance innovative technologies to improve patient care.

Inovalon’s Safety Management solution now on PointClickCare Marketplace

23andMe filed for bankruptcy on March 23, and announced that the company and its genetic data are up for sale. Here's how to delete your genetic data.